Home patients with diabetes trial a continuous glucose monitor
Part of Hormones & metabolism clinical trials.
This study tests a continuous glucose monitor (a sensor that tracks glucose) for people with type 1 or type 2 diabetes who receive care at home through Mayo’s Advanced Care at Home program. It may help by improving how safely and accurately blood sugar is followed while you’re at home.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are enrolled in Mayo’s Advanced Care at Home and will stay there at least 72 hours
- You have type 1 or type 2 diabetes
- You use insulin under the skin (either injections or an insulin pump)
- You can understand the study and sign the consent form
- You are not currently using a continuous glucose monitor (CGM) for insulin dosing or glucose checks
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new continuous glucose monitor (CGM) that checks your sugar levels day and night without frequent finger pricks. It may help you manage your diabetes better by showing glucose trends and alerts.
This study will look at how well Dexcom continuous glucose monitors (CGMs) work in real life. It helps people with diabetes track their blood sugar levels and may lead to better control of their condition.
This study tests whether using a small sensor (continuous glucose monitor) to check your blood sugar while you're in the hospital can improve diabetes management. You'll wear the sensor for a few days and may not need as many finger-prick tests.
This study looks at how people with diabetes feel about using a continuous glucose monitor (CGM) and their blood sugar readings. It aims to learn what works best for patients and healthcare providers to improve diabetes care.
This trial tests a new continuous glucose monitor (a small sensor that checks blood sugar levels) to see how well and safely it works in people with type 1 diabetes. You'll wear the sensor for 15 days and attend three clinic visits to check its accuracy against blood samples.
This study tests a continuous glucose monitor (a small sensor that tracks your blood sugar) for 20 days. It's for people with prediabetes to see how their blood sugar changes throughout the day and potentially help manage their condition.
Hear when a new Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.